BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

823 related articles for article (PubMed ID: 25559754)

  • 21. Sexual Quality of Life in Inflammatory Bowel Disease: A Multicenter, National-Level Study.
    Roseira J; Magro F; Fernandes S; Simões C; Portela F; Vieira AI; Patita M; Leal C; Lago P; Caldeira P; Gago T; Currais P; Dias CC; Santiago M; Dias S; Tavares de Sousa H
    Inflamm Bowel Dis; 2020 Apr; 26(5):746-755. PubMed ID: 31504518
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Impact of perceived stigma on inflammatory bowel disease patient outcomes.
    Taft TH; Keefer L; Leonhard C; Nealon-Woods M
    Inflamm Bowel Dis; 2009 Aug; 15(8):1224-32. PubMed ID: 19180581
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Inflammatory bowel disease: A descriptive study of 716 local Chilean patients.
    Simian D; Fluxá D; Flores L; Lubascher J; Ibáñez P; Figueroa C; Kronberg U; Acuña R; Moreno M; Quera R
    World J Gastroenterol; 2016 Jun; 22(22):5267-75. PubMed ID: 27298570
    [TBL] [Abstract][Full Text] [Related]  

  • 24. High Rates of Smoking Especially in Female Crohn's Disease Patients and Low Use of Supportive Measures to Achieve Smoking Cessation--Data from the Swiss IBD Cohort Study.
    Biedermann L; Fournier N; Misselwitz B; Frei P; Zeitz J; Manser CN; Pittet V; Juillerat P; von Känel R; Fried M; Vavricka SR; Rogler G;
    J Crohns Colitis; 2015 Oct; 9(10):819-29. PubMed ID: 26116554
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Influence of alexithymia on health-related quality of life in inflammatory bowel disease: are there any related factors?
    Iglesias-Rey M; Barreiro-de Acosta M; Caamaño-Isorna F; Vázquez Rodríguez I; Lorenzo González A; Bello-Paderne X; Domínguez-Muñoz JE
    Scand J Gastroenterol; 2012 Apr; 47(4):445-53. PubMed ID: 22300356
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The Short Inflammatory Bowel Disease Questionnaire: a quality of life instrument for community physicians managing inflammatory bowel disease. CCRPT Investigators. Canadian Crohn's Relapse Prevention Trial.
    Irvine EJ; Zhou Q; Thompson AK
    Am J Gastroenterol; 1996 Aug; 91(8):1571-8. PubMed ID: 8759664
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Impaired health-related quality of life in inflammatory bowel diseases: psychosocial impact and coping styles in a national German sample.
    Petrak F; Hardt J; Clement T; Börner N; Egle UT; Hoffmann SO
    Scand J Gastroenterol; 2001 Apr; 36(4):375-82. PubMed ID: 11336162
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Psychological factors are associated with changes in the health-related quality of life in inflammatory bowel disease.
    Iglesias-Rey M; Barreiro-de Acosta M; Caamaño-Isorna F; Rodríguez IV; Ferreiro R; Lindkvist B; González AL; Dominguez-Munoz JE
    Inflamm Bowel Dis; 2014 Jan; 20(1):92-102. PubMed ID: 24193152
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Medication non-adherence in adult patients affected by inflammatory bowel disease: a critical review and update of the determining factors, consequences and possible interventions.
    Lenti MV; Selinger CP
    Expert Rev Gastroenterol Hepatol; 2017 Mar; 11(3):215-226. PubMed ID: 28099821
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Influence of phenotype at diagnosis and of other potential prognostic factors on the course of inflammatory bowel disease.
    Romberg-Camps MJ; Dagnelie PC; Kester AD; Hesselink-van de Kruijs MA; Cilissen M; Engels LG; Van Deursen C; Hameeteman WH; Wolters FL; Russel MG; Stockbrügger RW
    Am J Gastroenterol; 2009 Feb; 104(2):371-83. PubMed ID: 19174787
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clinical Predictors of Future Nonadherence in Inflammatory Bowel Disease.
    Severs M; Mangen MJ; Fidder HH; van der Valk ME; van der Have M; van Bodegraven AA; Clemens CHM; Dijkstra G; Jansen JM; de Jong DJ; Mahmmod N; van de Meeberg PC; van der Meulen-de Jong AE; Pierik M; Ponsioen CY; Romberg-Camps MJL; Siersema PD; Jharap B; van der Woude JC; Zuithoff NPA; Oldenburg B
    Inflamm Bowel Dis; 2017 Sep; 23(9):1568-1576. PubMed ID: 28700534
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Health-related quality of life in inflammatory bowel disease in a Danish population-based inception cohort.
    Christiansen LK; Lo B; Bendtsen F; Vind I; Vester-Andersen MK; Burisch J
    United European Gastroenterol J; 2019 Aug; 7(7):942-954. PubMed ID: 31428419
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Mood disorders in inflammatory bowel disease: relation to diagnosis, disease activity, perceived stress, and other factors.
    Goodhand JR; Wahed M; Mawdsley JE; Farmer AD; Aziz Q; Rampton DS
    Inflamm Bowel Dis; 2012 Dec; 18(12):2301-9. PubMed ID: 22359369
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Characteristics of non-responders to self-reported questionnaires in a large inflammatory bowel disease cohort study.
    Multone E; Vader JP; Mottet C; Schoepfer A; Fournier N; Burnand B; Michetti P; Pittet V
    Scand J Gastroenterol; 2015; 50(11):1348-56. PubMed ID: 25921677
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Quality of life in Korean patients with inflammatory bowel diseases: ulcerative colitis, Crohn's disease and intestinal Behçet's disease.
    Kim WH; Cho YS; Yoo HM; Park IS; Park EC; Lim JG
    Int J Colorectal Dis; 1999 Feb; 14(1):52-7. PubMed ID: 10207731
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Quality of life, work productivity impairment and healthcare resources in inflammatory bowel diseases in Brazil.
    Parra RS; Chebli JMF; Amarante HMBS; Flores C; Parente JML; Ramos O; Fernandes M; Rocha JJR; Feitosa MR; Feres O; Scotton AS; Nones RB; Lima MM; Zaltman C; Goncalves CD; Guimaraes IM; Santana GO; Sassaki LY; Hossne RS; Bafutto M; Junior RLK; Faria MAG; Miszputen SJ; Gomes TNF; Catapani WR; Faria AA; Souza SCS; Caratin RF; Senra JT; Ferrari MLA
    World J Gastroenterol; 2019 Oct; 25(38):5862-5882. PubMed ID: 31636478
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Employment status, difficulties at work and quality of life in inflammatory bowel disease patients.
    De Boer AG; Bennebroek Evertsz' F; Stokkers PC; Bockting CL; Sanderman R; Hommes DW; Sprangers MA; Frings-Dresen MH
    Eur J Gastroenterol Hepatol; 2016 Oct; 28(10):1130-6. PubMed ID: 27340897
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Similar clinical characteristics of familial and sporadic inflammatory bowel disease in South Korea.
    Chung SH; Park SJ; Lee HS; Hong SP; Cheon JH; Kim TI; Kim WH
    World J Gastroenterol; 2014 Dec; 20(45):17120-6. PubMed ID: 25493025
    [TBL] [Abstract][Full Text] [Related]  

  • 39. E-health: Web-guided therapy and disease self-management in ulcerative colitis. Impact on disease outcome, quality of life and compliance.
    Elkjaer M
    Dan Med J; 2012 Jul; 59(7):B4478. PubMed ID: 22759851
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Guideline adherence and patient satisfaction in the treatment of inflammatory bowel disorders--an evaluation study.
    Pieper C; Haag S; Gesenhues S; Holtmann G; Gerken G; Jöckel KH
    BMC Health Serv Res; 2009 Jan; 9():17. PubMed ID: 19173739
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 42.